$CATX
Perspective Therapeutics Inc Stock $catx

$catx Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923023340 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$2.185M	$2.088M	$1.840M
YoY Change	27.26%	-16.65%	-34.66%
Cost Of Revenue	$1.447M	$1.840M	$1.430M
YoY Change	11.05%	16.53%	-10.4%
Gross Profit	$738.0K	$248.0K	$400.0K
YoY Change	78.26%	-73.22%	-67.21%
Gross Profit Margin	33.78%	11.88%	21.74%
Selling, General & Admin	$5.551M	$5.984M	$3.190M
YoY Change	41.82%	167.62%	37.5%
% of Gross Profit	752.17%	2412.9%	797.5%
Research & Development	$5.721M	$5.653M	$590.0K
YoY Change	708.05%	610.18%	10.28%
% of Gross Profit	775.2%	2279.44%	147.5%
Depreciation & Amortization	$269.0K	$260.0K	$80.00K
YoY Change	295.59%	246.67%	12.68%
% of Gross Profit	36.45%	104.84%	20.0%
Operating Expenses	$11.27M	$11.62M	$3.780M
YoY Change	143.88%	283.31%	32.4%
Operating Profit	-$10.53M	-$11.37M	-$3.380M
YoY Change	150.33%	440.08%	106.73%
Interest Expense	$14.00K	$28.00K	$420.0K
YoY Change	-90.0%	0.0%	1254.84%
% of Operating Profit
Other Income/Expense, Net	$178.0K	$268.0K
YoY Change	27.14%	857.14%
Pretax Income	-$10.36M	-$11.11M	-$3.270M
YoY Change	154.57%	434.46%	103.87%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$10.36M	-$11.11M	-$3.270M
YoY Change	154.57%	434.46%	103.87%
Net Earnings / Revenue	-473.96%	-531.9%	-177.72%
Basic Earnings Per Share	-$0.04	-$0.04
Diluted Earnings Per Share	-$0.04	-$0.04	-$0.02
COMMON SHARES
Basic Shares Outstanding	280.6M	280.1M	142.1M
Diluted Shares Outstanding		28.00M

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.98M	$28.30M	$43.80M
YoY Change	-66.77%	-49.36%	-27.43%
Cash & Equivalents	$18.00M	$28.32M	$20.99M
Short-Term Investments			$22.80M
Other Short-Term Assets	$961.0K	$1.400M	$600.0K
YoY Change	45.17%	5085.19%	12.15%
Inventory	$1.013M	$1.094M	$1.409M
Prepaid Expenses
Receivables	$1.731M	$1.113M	$1.363M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$21.69M	$31.95M	$53.22M
YoY Change	-62.31%	-46.14%	-16.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.012M	$7.043M	$1.684M
YoY Change	250.78%	256.43%	-14.65%
Goodwill	$27.32M	$27.32M	$0.00
YoY Change
Intangibles	$50.00M	$50.00M	$0.00
YoY Change
Long-Term Investments			$150.0K
YoY Change
Other Assets	$551.0K	$573.0K	$236.0K
YoY Change	445.54%	435.51%	114.55%
Total Long-Term Assets	$88.83M	$88.19M	$4.876M
YoY Change	1677.31%	1625.85%	33.66%
TOTAL ASSETS
Total Short-Term Assets	$21.69M	$31.95M	$53.22M
Total Long-Term Assets	$88.83M	$88.19M	$4.876M
Total Assets	$110.5M	$120.1M	$58.09M
YoY Change	76.72%	86.45%	-13.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.867M	$4.900M	$1.500M
YoY Change	54.99%	407.25%	77.1%
Accrued Expenses	$4.200M	$3.600M	$1.100M
YoY Change	178.88%	176.92%	10.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$48.00K	$100.0K
YoY Change
Total Short-Term Liabilities	$8.115M	$8.589M	$2.676M
YoY Change	102.82%	279.04%	45.04%
LONG-TERM LIABILITIES
Long-Term Debt	$1.689M	$1.700M	$0.00
YoY Change
Other Long-Term Liabilities	$1.944M	$1.200M	$800.0K
YoY Change	132.81%	33.93%	-21.26%
Total Long-Term Liabilities	$3.633M	$2.900M	$800.0K
YoY Change	335.09%	223.66%	-21.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.115M	$8.589M	$2.676M
Total Long-Term Liabilities	$3.633M	$2.900M	$800.0K
Total Liabilities	$11.75M	$11.49M	$3.449M
YoY Change	142.93%	263.44%	20.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.8M	-$117.4M	-$105.9M
YoY Change	24.48%	19.08%	11.31%
Common Stock	$226.5M	$226.1M	$160.6M
YoY Change	41.26%	41.4%	0.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$98.77M	$108.7M	$54.64M
YoY Change
Total Liabilities & Shareholders Equity	$110.5M	$120.1M	$58.09M
YoY Change	76.72%	86.45%	-13.62%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$10.36M	-$11.11M	-$3.270M
YoY Change	154.57%	434.46%	103.87%
Depreciation, Depletion And Amortization	$269.0K	$260.0K	$80.00K
YoY Change	295.59%	246.67%	12.68%
Cash From Operating Activities	-$10.11M	-$8.080M	-$4.330M
YoY Change	473.45%	179.49%	229.78%
INVESTING ACTIVITIES
Capital Expenditures	$227.0K	$570.0K	$60.00K
YoY Change	152.22%	-563.41%	-174.07%
Acquisitions
YoY Change
Other Investing Activities	$3.000K	$0.00	$6.390M
YoY Change	-100.01%
Cash From Investing Activities	-$227.0K	-$570.0K	$6.330M
YoY Change	-99.35%	363.41%	-7914.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000K	510.0K	0.000
YoY Change	-96.43%		-100.0%
NET CHANGE
Cash From Operating Activities	-10.11M	-8.080M	-4.330M
Cash From Investing Activities	-227.0K	-570.0K	6.330M
Cash From Financing Activities	1.000K	510.0K	0.000
Net Change In Cash	-10.34M	-8.140M	2.000M
YoY Change	-71.99%	170.07%	-249.48%
FREE CASH FLOW
Cash From Operating Activities	-$10.11M	-$8.080M	-$4.330M
Capital Expenditures	$227.0K	$570.0K	$60.00K
Free Cash Flow	-$10.34M	-$8.650M	-$4.390M
YoY Change	457.85%	212.5%	256.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	280479421
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	280479421
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	142112766
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	142112766
	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	136545075
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33407
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1458152
	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 Hills St., Suite 106
	dei	Entity Address City Or Town EntityAddressCityOrTown	Richland
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	99354
	dei	City Area Code CityAreaCode	509
	dei	Local Phone Number LocalPhoneNumber	375-1202
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	CATX
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	280571026
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28319000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20993000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	22764000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1113000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1363000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1094000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1409000	usd
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	6109000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1428000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	577000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	31954000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	53215000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7043000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1684000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	378000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	2269000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2396000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Goodwill Goodwill	27319000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	573000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	236000	usd
CY2023Q2	us-gaap	Assets Assets	120145000	usd
CY2022Q4	us-gaap	Assets Assets	58091000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4906000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1541000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	262000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	276000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	387000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	233000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	129000	usd
CY2023Q2	catx	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	2259000	usd
CY2022Q4	catx	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	212000	usd
CY2023Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	684000	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	285000	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	71000	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	0	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8589000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2676000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	543000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	116000	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1701000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	659000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	657000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	11492000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3449000	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	280000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	142000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225782000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	160432000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-117409000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-105932000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	108653000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	54642000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120145000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58091000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1500000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2505000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3330000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5415000	usd
CY2023Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	588000	usd
CY2022Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	821000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	usd
CY2023Q2	us-gaap	Revenues Revenues	2088000	usd
CY2022Q2	us-gaap	Revenues Revenues	2505000	usd
	us-gaap	Revenues Revenues	4151000	usd
	us-gaap	Revenues Revenues	5415000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1840000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1579000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3416000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3048000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	248000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	926000	usd
	us-gaap	Gross Profit GrossProfit	735000	usd
	us-gaap	Gross Profit GrossProfit	2367000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5653000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	796000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9510000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1345000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	911000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	654000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1723000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1341000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5073000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1582000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12096000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3163000	usd
CY2023Q2	catx	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	15000	usd
CY2022Q2	catx	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	-0	usd
	catx	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	15000	usd
	catx	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	-0	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-22000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	11622000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3032000	usd
	us-gaap	Operating Expenses OperatingExpenses	23336000	usd
	us-gaap	Operating Expenses OperatingExpenses	5849000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11374000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2106000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22601000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3482000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	294000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	28000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	668000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	57000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	28000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	-0	usd
	us-gaap	Interest Expense InterestExpense	46000	usd
	us-gaap	Interest Expense InterestExpense	-0	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2000	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	268000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	624000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	57000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11106000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2078000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21977000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3425000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11106000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2078000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11477000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3425000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	279988000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142040000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	254432000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142040000
	us-gaap	Net Income Loss NetIncomeLoss	-11477000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3425000	usd
	catx	Noncash Expense Lease NoncashExpenseLease	-14000	usd
	catx	Noncash Expense Lease NoncashExpenseLease	4000	usd
	us-gaap	Depreciation Depreciation	425000	usd
	us-gaap	Depreciation Depreciation	129000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	298000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	17000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	16000	usd
	catx	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	15000	usd
	catx	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	-0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2567000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	311000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-10500000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-250000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-144000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1920000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	445000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-100000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	397000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	117000	usd
	catx	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	154000	usd
	catx	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	-3000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-109000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	17000	usd
	catx	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	405000	usd
	catx	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	286000	usd
	catx	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	66000	usd
	catx	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	-6000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17795000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4315000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	756000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	131000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18000	usd
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	22764000	usd
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	0	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	2699000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	24689000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-149000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	35000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	532000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	65000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	432000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7326000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4464000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21175000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	60536000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28501000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56072000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28319000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55890000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28501000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56072000	usd
	catx	Noncash Or Part Noncash Acquisition Value Of Assets Acquired Including Goodwill NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredIncludingGoodwill	85885000	usd
	catx	Noncash Or Part Noncash Acquisition Value Of Assets Acquired Including Goodwill NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredIncludingGoodwill	0	usd
	us-gaap	Stock Issued1 StockIssued1	54618000	usd
	us-gaap	Stock Issued1 StockIssued1	-0	usd
	catx	Noncash Or Part Noncash Acquisition Assumption Of Stock Options And Warrants NoncashOrPartNoncashAcquisitionAssumptionOfStockOptionsAndWarrants	-7836000	usd
	catx	Noncash Or Part Noncash Acquisition Assumption Of Stock Options And Warrants NoncashOrPartNoncashAcquisitionAssumptionOfStockOptionsAndWarrants	0	usd
	catx	Noncash Or Part Noncash Acquisition Notes Receivable And Accrued Interest Forgiven NoncashOrPartNoncashAcquisitionNotesReceivableAndAccruedInterestForgiven	-6171000	usd
	catx	Noncash Or Part Noncash Acquisition Notes Receivable And Accrued Interest Forgiven NoncashOrPartNoncashAcquisitionNotesReceivableAndAccruedInterestForgiven	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	17260000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	557000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	64391000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	157000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1347000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	63201000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	154000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2078000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	61277000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	54642000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	54553000	usd
CY2023Q1	catx	Adjustments To Additional Paid In Capital Assumption Of Stock Options And Warrants At Fair Value AdjustmentsToAdditionalPaidInCapitalAssumptionOfStockOptionsAndWarrantsAtFairValue	7836000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1368000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-371000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	118028000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	532000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1199000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11106000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	108653000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management of the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes of the Company including the fair value of net assets acquired in a business combination; the allowance for doubtful accounts receivable; net realizable value of the enriched barium inventory; the estimated useful lives used in calculating depreciation and amortization on the Company’s fixed assets, patents, trademarks, intangible assets and other assets; estimated amount and fair value of the asset retirement obligation related to the Company’s production facilities; equity method investment; and inputs to the Black-Scholes calculation used in determining the expense related to share-based compensation including volatility and estimated lives of options granted and impairment of long-lived assets including intangible assets and goodwill. Accordingly, actual results could differ from those estimates and affect the amounts reported in the financial statements.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"></p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	50000000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q4	catx	Indefinitelived Intangible Assets Accumulated Amortization IndefinitelivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50904000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9560000
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	781000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	752000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	295000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	636000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	21000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1094000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1409000	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	2269000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2396000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15085000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9315000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8042000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7631000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7043000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1684000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	27300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	27319000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Goodwill	27319000	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	50000000	usd
CY2023Q2	catx	Indefinitelived Intangible Assets Accumulated Amortization IndefinitelivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1199000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	154000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2567000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	311000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3896000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7268035
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M13D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	205000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.30
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	226560
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.84
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	332450
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.83
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6914025
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.70
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M4D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4432121
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M29D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10806200
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.56
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y11M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13105000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.51
	catx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Assumed In Period Gross SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedInPeriodGross	24263424
	catx	Sharebased Compensation Arrangements By Sharebased Payment Award Options Assumed In Period Weighted Average Exercise Price SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice	0.17
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1821580
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	808300
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	673888
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.64
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	44870856
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.35
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M17D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13706000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	35023775
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.30
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y7M17D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	12496	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10305000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	205000
CY2023Q2	catx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	4506000	usd
CY2022Q2	catx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	47000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	808300
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	142485
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	673888
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	74975
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1821580
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	570000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13105000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	205000
	catx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	5355000	usd
	catx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	47000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	808300
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	226560
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	673888
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	332450
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1821580
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	570000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	13105000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	86000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	77000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	156000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	159000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	319000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	319000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	106000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	903000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	98000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	805000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	262000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	543000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	657000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	624000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	17000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	16000	usd
	catx	Gain On Change In Aro Estimate GainOnChangeInAroEstimate	-15000	usd
	catx	Gain On Change In Aro Estimate GainOnChangeInAroEstimate	0	usd
CY2023Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	659000	usd
CY2022Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	640000	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	1772000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	0	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	71000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	-0	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1701000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	47000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	49000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	52000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	55000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1569000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	1772000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q2	us-gaap	Revenues Revenues	2088000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	248000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11374000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	294000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	28000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	255000	usd
CY2022Q2	us-gaap	Revenues Revenues	2505000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	926000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2106000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	28000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75000	usd
	us-gaap	Revenues Revenues	4151000	usd
	us-gaap	Gross Profit GrossProfit	735000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22601000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	668000	usd
	us-gaap	Interest Expense InterestExpense	46000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	445000	usd
	us-gaap	Revenues Revenues	5415000	usd
	us-gaap	Gross Profit GrossProfit	2367000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3482000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	57000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	6170000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2088000	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3033000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-11106000	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-5311000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4151000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	6161000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-17365000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-3714000	usd

Files In Submission

Name	View Source	Status
0001437749-23-023340-index-headers.html	Edgar Link	pending
0001437749-23-023340-index.html	Edgar Link	pending
0001437749-23-023340.txt	Edgar Link	pending
0001437749-23-023340-xbrl.zip	Edgar Link	pending
catx-20230630.xsd	Edgar Link	pending
ex_547563.htm	Edgar Link	pending
ex_547564.htm	Edgar Link	pending
ex_547565.htm	Edgar Link	pending
ex_547566.htm	Edgar Link	pending
ex_558773.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
isr20230630c_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
catx-20230630_def.xml	Edgar Link	unprocessable
catx-20230630_lab.xml	Edgar Link	unprocessable
catx-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
isr20230630c_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
catx-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CATX
Perspective Therapeutics Inc Stock $catx

2023 Q3 Form 10-Q Financial Statement

#000143774923023340 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX Perspective Therapeutics Inc Stock $catx

2023 Q3 Form 10-Q Financial Statement

#000143774923023340 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX
Perspective Therapeutics Inc Stock $catx